A new discovery about selective serotonin reuptake inhibitors suggests that these drugs, used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. Researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs. Such secondary pathways could help explain why different people taking the same drug can experience different effects, and could also lead to new types of drugs altogether.